Business · 27/01/2012Updated: 10/17/2026 · 1 min read
FDA Approves New Dosage Regimen for Danofloxacin in Beef Cattle
Summary
The FDA is amending its regulations to reflect approval of a supplemental NADA for Pfizer's danofloxacin mesylate injectable solution, which will allow for an additional dosage regimen for treating bovine respiratory disease in beef cattle.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →